Our Lung cancer surgery Techniques: What Suits You Best?
When considering Lung cancer surgery, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:
Lobectomy
 Lobectomy is a surgical procedure that removes one lobe of the lung to treat lung cancer or other lung diseases.
 Pros: Lobectomy is less invasive than pneumonectomy and preserves more lung function. It has a high success rate of around 85% for early-stage lung cancer.
 Cons: It may not be suitable for patients with widespread lung damage or tumors in multiple lobes. Recovery can be longer compared to wedge resection.
 Best for: Early-stage lung cancer, localized tumors, and non-small cell lung cancer in patients.
 Prices: Cost of Lobectomy in United Kingdom from $40,000 Wedge Resection
 A surgical procedure that removes a small, wedge-shaped part of the lung containing a tumor or abnormal tissue.
 Pros: Less invasive than lobectomy or pneumonectomy, preserving more lung function. Typically results in a shorter hospital stay, with only 1-3 days required.
 Cons: Higher recurrence rates compared to lobectomy, with approximately 10% more cases. Not suitable for larger tumors or those near major blood vessels.
 Effectiveness: 95% success rate in removing small, localized tumors.
 Best for: Small, early-stage lung tumors, particularly in patients with limited lung function.
 Lung segmentectomy
 A pulmonary surgery that involves removing a specific segment of the lung affected by disease, often used to treat localized lung cancer.
 Pros: Preserves more lung function compared to lobectomy. Less invasive than pneumonectomy, with fewer complications. Allows for targeted tumor excision, minimizing healthy tissue removal.
 Cons: May not be suitable for large or multiple tumors. Slightly higher recurrence risk compared to lobectomy at 10%.
 Effectiveness: Success rate is approximately 85-90% for early-stage lung cancer.
 Best for: Patients with small, localized tumors, especially in early-stage lung cancer.